Systematic review of novel ablative methods in locally advanced pancreatic cancer

World Journal of Gastroenterology

Volumn 20, Issue 9, 2014, Pages 2267-2278

  Keane, Margaret G ^a   Bramis, Konstantinos ^b   Pereira, Stephen P ^a   Fusai, Giuseppe K ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Cryoablation; High frequency focused ultrasound; Irreversible electroporation; Microwave ablation; Pancreatic cancer; Photodynamic therapy; Radiofrequency ablation

Indexed keywords

ABLATION THERAPY; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CRYOABLATION; ENDOSCOPIC ECHOGRAPHY; ERBIUM YAG LASER; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MICROWAVE THERAPY; MORBIDITY; OVERALL SURVIVAL; PANCREAS CANCER; PHOTODYNAMIC THERAPY; RADIOFREQUENCY ABLATION; SELF EXPANDING STENT; CARCINOMA, PANCREATIC DUCTAL; CATHETER ABLATION; CRYOSURGERY; ELECTROPORATION; LOW LEVEL LASER THERAPY; MICROWAVE RADIATION; PANCREATIC NEOPLASMS; PATHOLOGY; PRECANCEROUS CONDITIONS; THERAPEUTIC USE; TREATMENT OUTCOME;

ABLATION TECHNIQUES; CARCINOMA, PANCREATIC DUCTAL; CATHETER ABLATION; CRYOSURGERY; ELECTROPORATION; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; LASER THERAPY; MICROWAVES; PANCREATIC NEOPLASMS; PRECANCEROUS CONDITIONS; TREATMENT OUTCOME;

EID: 84895870186     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i9.2267     Document Type: Article

References (84)

1. Cancer Research UK. Pancreatic cancer statistics 2010. Available from: URL: http://www.cancerresearchuk.org/cancerinfo/ cancerstats/types/pancreas
2. Cunningham D, Chau I, Stocken DD, Valle JW, Smith D, Steward W, Harper PG, Dunn J, Tudur-Smith C, West J, Falk S, Crellin A, Adab F, Thompson J, Leonard P, Ostrowski J, Eatock M, Scheithauer W, Herrmann R, Neoptolemos JP. Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. J Clin Oncol 2009; 27: 5513-5518 [PMID: 19858379]
3. Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardière C, Bennouna J, Bachet JB, Khemissa-Akouz F, Péré-Vergé D, Delbaldo C, Assenat E, Chauffert B, Michel P, Montoto-Grillot C, Ducreux M. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011; 364: 1817-1825 [PMID: 21561347 DOI: 10.1056/NEJMoa1011923]
4. VonHoff DD, Ervin TJ, Arena FP, Chiorean EG, Infante JR, Moore MJ, Seay TE, Tjulandin S, Ma WW, Saleh MN, Harris M, Reni M, Ramanathan RK, Tabernero J, Hidalgo M, Van Cutsem E, Goldstein D, Wei X, Iglesias JL, Renschler MF. Randomized phase III study of weekly nab-paclitaxel plus gemcitabine vs gemcitabine alone in patients with metastatic adenocarcinoma of the pancreas (MPACT). J Clin Oncol 2013; 30 supp 34: abstr LBA148
5. Gillen S, Schuster T, Friess H, Kleeff J. Palliative resections versus palliative bypass procedures in pancreatic cancer--a systematic review. Am J Surg 2012; 203: 496-502 [PMID: 21872208 DOI: 10.1016/j.amjsurg.2011.05.004]
6. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329-338 [PMID: 10518312 DOI: 10.1055/s-2007-1007122]
7. Girelli R, Frigerio I, Salvia R, Barbi E, Tinazzi Martini P, Bassi C. Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer. Br J Surg 2010; 97: 220-225 [PMID: 20069610 DOI: 10.1002/bjs.6800]
8. Goldberg SN, Mallery S, Gazelle GS, Brugge WR. EUSguided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc 1999; 50: 392-401 [PMID: 10462663 DOI: 10.1053/ge.1999.v50.98847]
9. Date RS, Siriwardena AK. Radiofrequency ablation of the pancreas. II: Intra-operative ablation of non-resectable pancreatic cancer. A description of technique and initial outcome. JOP 2005; 6: 588-592 [PMID: 16286710]
10. Wu Y, Tang Z, Fang H, Gao S, Chen J, Wang Y, Yan H. High operative risk of cool-tip radiofrequency ablation for unresectable pancreatic head cancer. J Surg Oncol 2006; 94: 392-395 [PMID: 16967436 DOI: 10.1002/jso.20580]
11. Spiliotis JD, Datsis AC, Michalopoulos NV, Kekelos SP, Vaxevanidou A, Rogdakis AG, Christopoulou AN. Radiofrequency ablation combined with palliative surgery may prolong survival of patients with advanced cancer of the pancreas. Langenbecks Arch Surg 2007; 392: 55-60 [PMID: 17089173 DOI: 10.1007/s00423-006-0098-5]
12. Matsui Y, Nakagawa A, Kamiyama Y, Yamamoto K, Kubo N, Nakase Y. Selective thermocoagulation of unresectable pancreatic cancers by using radiofrequency capacitive heating. Pancreas 2000; 20: 14-20 [PMID: 10630378]
13. Elias D, Baton O, Sideris L, Lasser P, Pocard M. Necrotizing pancreatitis after radiofrequency destruction of pancreatic tumours. Eur J Surg Oncol 2004; 30: 85-87 [PMID: 14736529]
14. Hadjicostas P, Malakounides N, Varianos C, Kitiris E, Lerni F, Symeonides P. Radiofrequency ablation in pancreatic cancer. HPB (Oxford) 2006; 8: 61-64 [PMID: 18333241 DOI: 10.1080/13651820500466673]
15. Date RS, McMahon RF, Siriwardena AK. Radiofrequency ablation of the pancreas. I: Definition of optimal thermal kinetic parameters and the effect of simulated portal venous circulation in an ex-vivo porcine model. JOP 2005; 6: 581-587 [PMID: 16286709]
16. Tang Z, Wu YL, Fang HQ, Xu J, Mo GQ, Chen XM, Gao SL, Li JT, Liu YB, Wang Y. Treatment of unresectable pancreatic carcinoma by radiofrequency ablation with 'cool-tip needle': report of 18 cases. Zhonghua Yi Xue Za Zhi 2008; 88: 391-394 [PMID: 18581892]
17. Varshney S, Sewkani A, Sharma S, Kapoor S, Naik S, Sharma A, Patel K. Radiofrequency ablation of unresectable pancreatic carcinoma: feasibility, efficacy and safety. JOP 2006; 7: 74-78 [PMID: 16407624]
18. Siriwardena AK. Radiofrequency ablation for locally advanced cancer of the pancreas. JOP 2006; 7: 1-4 [PMID: 16407612]
19. Arcidiacono PG, Carrara S, Reni M, Petrone MC, Cappio S, Balzano G, Boemo C, Cereda S, Nicoletti R, Enderle MD, Neugebauer A, von Renteln D, Eickhoff A, Testoni PA. Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer. Gastrointest Endosc 2012; 76: 1142-1151 [PMID: 23021160 DOI: 10.1016/ j.gie.2012.08.006]
20. Pai M, Yang J, Zhang X, Jin Z, Wang D, Senturk H, Lakhtakia S, Reddy DN, Kahaleh M, Habib N, Brugge WR. Endoscopic ultrasound guided radiofrequency ablation (EUSRFA) for pancreatic ductal adenocarcinoma. Gut 2013; 62 (Suppl 1): A153
21. Pai M, Senturk H, Lakhtakia S, Reddy DN, Cicinnati C, Kabar I, Beckebaum S, Jin Z, Wang D, Yang J, Zhang X, Habib N, Brugge WR. Endoscopic Ultrasound Guided Radiofrequency Ablation (EUS-RFA) for Cystic Neoplasms and Neuroendocrine Tumours of the Pancreas. Gastrointest Endosc 2013; 77 (5S): AB143-AB144
22. Carrafiello G, Ierardi AM, Fontana F, Petrillo M, Floridi C, Lucchina N, Cuffari S, Dionigi G, Rotondo A, Fugazzola C. Microwave ablation of pancreatic head cancer: safety and efficacy. J Vasc Interv Radiol 2013; 24: 1513-1520 [PMID: 24070507 DOI: 10.1016/j.jvir.2013.07.005]
23. Lygidakis NJ, Sharma SK, Papastratis P, Zivanovic V, Kefalourous H, Koshariya M, Lintzeris I, Porfiris T, Koutsiouroumba D. Microwave ablation in locally advanced pancreatic carcinoma--a new look. Hepatogastroenterology 2007; 54: 1305-1310 [PMID: 17708242]
24. Myers RS, Hammond WG, Ketcham AS. Cryosurgery of primate pancreas. Cancer 1970; 25: 411-414 [PMID: 4983998]
25. Patiutko IuI, Barkanov AI, Kholikov TK, Lagoshnyǐ AT, Li LI, Samoǐlenko VM, Afrikian MN, Savel'eva EV. The combined treatment of locally disseminated pancreatic cancer using cryosurgery. Vopr Onkol 1991; 37: 695-700 [PMID: 1843146]
26. Xu KC, Niu LZ, Hu YZ, He WB, He YS, Zuo JS. Cryosurgery with combination of (125)iodine seed implantation for the treatment of locally advanced pancreatic cancer. J Dig Dis 2008; 9: 32-40 [PMID: 18251792 DOI: 10.1111/ j.1443-9573.2007.00322.x]
27. Korpan NN. Cryosurgery: ultrastructural changes in pancreas tissue after low temperature exposure. Technol Cancer Res Treat 2007; 6: 59-67 [PMID: 17375968]
28. Joosten JJ, Muijen GN, Wobbes T, Ruers TJ. In vivo destruction of tumor tissue by cryoablation can induce inhibition of secondary tumor growth: an experimental study. Cryobiology 2001; 42: 49-58 [PMID: 11336489 DOI: 10.1006/ cryo.2001.2302]
29. Niu L, Chen J, He L, Liao M, Yuan Y, Zeng J, Li J, Zuo J, Xu K. Combination treatment with comprehensive cryoablation and immunotherapy in metastatic pancreatic cancer. Pancreas 2013; 42: 1143-1149 [PMID: 23899940 DOI: 10.1097/ MPA.0b013e3182965dde]
30. Bown SG, Rogowska AZ, Whitelaw DE, Lees WR, Lovat LB, Ripley P, Jones L, Wyld P, Gillams A, Hatfield AW. Photodynamic therapy for cancer of the pancreas. Gut 2002; 50: 549-557 [PMID: 11889078]
31. Huggett MT, Jermyn M, Gillams A, Mosse S, Kent E, Bown SG, Hasan T, Pogue BW, Pereira SP. Photodynamic therapy of locally advanced pancreatic cancer (VERTPAC study): Final clinical results. Progress in Biomedical Optics and Imaging-Proceedings of SPIE 2013; 8568
32. Huggett MT, Jermyn M, Gillams A, Mosse S, Kent E, Bown SG, Hasan T, Pogue BW, Pereira SP. Photodynamic therapy for locally advanced pancreatic cancer (VERTPAC study): final clinical results. Pancreatology 2013; 13: e2-e3
33. Ayaru L, Wittmann J, Macrobert AJ, Novelli M, Bown SG, Pereira SP. Photodynamic therapy using verteporfin photosensitization in the pancreas and surrounding tissues in the Syrian golden hamster. Pancreatology 2007; 7: 20-27 [PMID: 17449962]
34. Di Matteo F, Martino M, Rea R, Pandolfi M, Rabitti C, Masselli GM, Silvestri S, Pacella CM, Papini E, Panzera F, Valeri S, Coppola R, Costamagna G. EUS-guided Nd: YAG laser ablation of normal pancreatic tissue: a pilot study in a pig model. Gastrointest Endosc 2010; 72: 358-363 [PMID: 20541187 DOI: 10.1016/j.gie.2010.02.027]
35. Leslie T, Ritchie R, Illing R, Ter Haar G, Phillips R, Middleton M, Bch B, Wu F, Cranston D. High-intensity focused ultrasound treatment of liver tumours: post-treatment MRI correlates well with intra-operative estimates of treatment volume. Br J Radiol 2012; 85: 1363-1370 [PMID: 22700259 DOI: 10.1259/bjr/56737365]
36. Hwang J, Farr N, Morrison K. Development of an EUS-guided high-intensity focused ultrasound endoscope. Gastrointest Endosc 2011; 73 (4S): AB155
37. Narayanan G, Hosein PJ, Arora G, Barbery KJ, Froud T, Livingstone AS, Franceschi D, Rocha Lima CM, Yrizarry J. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. J Vasc Interv Radiol 2012; 23: 1613-1621 [PMID: 23177107 DOI: 10.1016/j.jvir.2012.09.012]
38. Zoepf T, Jakobs R, Arnold JC, Apel D, Riemann JF. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol 2005; 100: 2426-2430 [PMID: 16279895 DOI: 10.1111/j.1572-0241.2005.00318.x]
39. Gerhardt T, Rings D, Höblinger A, Heller J, Sauerbruch T, Schepke M. Combination of bilateral metal stenting and trans-stent photodynamic therapy for palliative treatment of hilar cholangiocarcinoma. Z Gastroenterol 2010; 48: 28-32 [PMID: 20072993 DOI: 10.1055/s-0028-1109983]
40. Pereira SP, Hughes SK, Roughton M, O'Donoghue P, Wasan HS, Valle J, Bridgewater J. Photostent-02: porfimer sodium photodynamic therapy plus stenting alone in patients (pts) with advanced or metastatic cholangiocarcinomas and other biliary tract tumours (BTC): a multicentre, randomised phase III trial [abstract]; 2010 Oct 8-12; London. Milan, Italy: ESMO, 2010: Abstract 802O
41. Steel AW, Postgate AJ, Khorsandi S, Nicholls J, Jiao L, Vlavianos P, Habib N, Westaby D. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest Endosc 2011; 73: 149-153 [PMID: 21184881 DOI: 10.1016/j.gie.2010.09.031]
42. Figueroa-Barojas P, Bakhru MR, Habib NA, Ellen K, Millman J, Jamal-Kabani A, Gaidhane M, Kahaleh M. Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: a novel palliation technique. J Oncol 2013; 2013: 910897 [PMID: 23690775 DOI: 10.1155/2013/910897]
43. Shariff MI, Khan SA, Westaby D. The palliation of cholangiocarcinoma. Curr Opin Support Palliat Care 2013; 7: 168-174 [PMID: 23422512 DOI: 10.1097/SPC.0b013e32835f1e2f]
44. The National Institute for Health and Care Excellence. Using radiofrequency energy to treat malignant bile or pancreatic duct obstructions caused by cholangiocarcinoma or pancreatic adenocarcinoma 2013. Available from: URL: http://guidance.nice.org.uk/IPG464/DraftGuidance
45. Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, Kimura W, Levy P, Pitman MB, Schmidt CM, Shimizu M, Wolfgang CL, Yamaguchi K, Yamao K. In-ternational consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012; 12: 183-197 [PMID: 22687371 DOI: 10.1016/j.pan.2012.04.004]
46. Gan SI, Thompson CC, Lauwers GY, Bounds BC, Brugge WR. Ethanol lavage of pancreatic cystic lesions: initial pilot study. Gastrointest Endosc 2005; 61: 746-752 [PMID: 15855986]
47. Oh HC, Seo DW, Song TJ, Moon SH, Park do H, Soo Lee S, Lee SK, Kim MH, Kim J. Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts. Gastroenterology 2011; 140: 172-179 [PMID: 20950614]
48. Barclay RL, Perez-Miranda M, Giovannini M. EUSguided treatment of a solid hepatic metastasis. Gastrointest Endosc 2002; 55: 266-270 [PMID: 11818938 DOI: 10.1067/ mge.2002.120784]
49. Günter E, Lingenfelser T, Eitelbach F, Müller H, Ell C. EUSguided ethanol injection for treatment of a GI stromal tumor. Gastrointest Endosc 2003; 57: 113-115 [PMID: 12518147 DOI: 10.1067/mge.2003.39]
50. Girelli R, Giardino A, Frigerio I, Salvia R, Partelli S, Bassi C. Survival after radiofrequency of stage III pancreatic carcinoma: a wind of change? HPB (Oxford) 2011; 13 (Suppl 2): 15
51. Giardino A, Girelli R, Frigerio I, Regi P, Cantore M, Alessandra A, Lusenti A, Salvia R, Bassi C, Pederzoli P. Triple approach strategy for patients with locally advanced pancreatic carcinoma. HPB (Oxford) 2013; 15: 623-627 [PMID: 23458679 DOI: 10.1111/hpb.12027]
52. Kovach SJ, Hendrickson RJ, Cappadona CR, Schmidt CM, Groen K, Koniaris LG, Sitzmann JV. Cryoablation of unresectable pancreatic cancer. Surgery 2002; 131: 463-464 [PMID: 11935137]
53. Li B, Li JD, Chen XL, Zeng Y, Wen TF, Hu WM, Yan LN. Cryosurgery for unresectable pancreatic carcinoma: a report of 44 cases. Zhonghua Gandan Waike Zazhi 2004; 10: 523-525
54. Wu Q, Zhang JX, Qian JX, Xu Q, Wang JJ. The application of surgical treatment in combination with targeted cryoablation on advanced carcinoma of head of pancreas: a report of 15 cases. Zhongguo Zhongliu Linchuang 2005; 32: 1403-1405
55. Yi FT, Song HZ, Li J. Intraoperative Ar-He targeted cryoablation for advanced pancreatic carcinoma. Zhonghua Gandan Waike Zazhi 2006; 12: 186-187
56. Xu KC, Niu LZ, Hu YZ, He WB, He YS, Li YF, Zuo JS. A pilot study on combination of cryosurgery and (125)iodine seed implantation for treatment of locally advanced pancreatic cancer. World J Gastroenterol 2008; 14: 1603-1611 [PMID: 18330956]
57. Li J, Chen X, Yang H, Wang X, Yuan D, Zeng Y, Wen T, Yan L, Li B. Tumour cryoablation combined with palliative bypass surgery in the treatment of unresectable pancreatic cancer: a retrospective study of 142 patients. Postgrad Med J 2011; 87: 89-95 [PMID: 21131612 DOI: 10.1136/pgmj.2010.098350]
58. Xu K, Niu L, Yang D. Cryosurgery for pancreatic cancer. Gland Surgery 2013; 2: 30-39
59. Wang X, Sun J. High-intensity focused ultrasound in patients with late-stage pancreatic carcinoma. Chin Med J (Engl) 2002; 115: 1332-1335 [PMID: 12411106]
60. Xie DR, Chen D, Teng H. A multicenter non-randomized clinical study of high intensity focused ultrasound in treating patients with local advanced pancreatic carcinoma. Zhongguo Zhongliu Linchuang 2003; 30: 630-634
61. Xu YQ, Wang GM, Gu YZ, Zhang HF. The acesodyne effect of high intensity focused ultrasound on the treatment of advanced pancreatic carcinoma. Zhongguo Linchuang Yixue 2003; 10: 322-323
62. Yuan C, Yang L, Yao C. Observation of high intensity focused ultrasound treating 40 cases of pancreatic cancer. Linchuang Gandanbing Zazhi 2003; 19: 145-146
63. Wu F, Wang ZB, Zhu H, Chen WZ, Zou JZ, Bai J, Li KQ, Jin CB, Xie FL, Su HB. Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience. Radiology 2005; 236: 1034-1040 [PMID: 16055692 DOI: 10.1148/radiol.2362041105]
64. Xiong LL, Hwang JH, Huang XB, Yao SS, He CJ, Ge XH, Ge HY, Wang XF. Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer. JOP 2009; 10: 123-129 [PMID: 19287104]
65. Zhao H, Yang G, Wang D, Yu X, Zhang Y, Zhu J, Ji Y, Zhong B, Zhao W, Yang Z, Aziz F. Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer. Anticancer Drugs 2010; 21: 447-452 [PMID: 20075714 DOI: 10.1097/ CAD.0b013e32833641a7]
66. Orsi F, Zhang L, Arnone P, Orgera G, Bonomo G, Vigna PD, Monfardini L, Zhou K, Chen W, Wang Z, Veronesi U. High-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locations. AJR Am J Roentgenol 2010; 195: W245-W252 [PMID: 20729423 DOI: 10.2214/ajr.09.3321]
67. Sung HY, Jung SE, Cho SH, Zhou K, Han JY, Han ST, Kim JI, Kim JK, Choi JY, Yoon SK, Yang JM, Han CW, Lee YS. Longterm outcome of high-intensity focused ultrasound in advanced pancreatic cancer. Pancreas 2011; 40: 1080-1086 [PMID: 21926543 DOI: 10.1097/MPA.0b013e31821fde24]
68. Wang K, Chen Z, Meng Z, Lin J, Zhou Z, Wang P, Chen L, Liu L. Analgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancer. Int J Hyperthermia 2011; 27: 101-107 [PMID: 21219135 DOI: 10.3109/02656736.20 10.525588]
69. Lee JY, Choi BI, Ryu JK, Kim YT, Hwang JH, Kim SH, Han JK. Concurrent chemotherapy and pulsed high-intensity focused ultrasound therapy for the treatment of unresectable pancreatic cancer: initial experiences. Korean J Radiol 2011; 12: 176-186 [PMID: 21430934 DOI: 10.3348/kjr.2011.12.2.176]
70. Li PZ, Zhu SH, He W, Zhu LY, Liu SP, Liu Y, Wang GH, Ye F. High-intensity focused ultrasound treatment for patients with unresectable pancreatic cancer. Hepatobiliary Pancreat Dis Int 2012; 11: 655-660 [PMID: 23232639]
71. Wang K, Zhu H, Meng Z, Chen Z, Lin J, Shen Y, Gao H. Safety evaluation of high-intensity focused ultrasound in patients with pancreatic cancer. Onkologie 2013; 36: 88-92 [PMID: 23485995 DOI: 10.1159/000348530]
72. High Intensity Focused Ultrasound Treatment for Patients with Local Advanced Pancreatic Cancer. Hepatogastroenterology 2013; 60: Epub ahead of print [PMID: 24088318 DOI: 10.5754/hge13498]
73. Oh HC, Seo DW, Lee TY, Kim JY, Lee SS, Lee SK, Kim MH. New treatment for cystic tumors of the pancreas: EUSguided ethanol lavage with paclitaxel injection. Gastrointest Endosc 2008; 67: 636-642 [PMID: 18262182 DOI: 10.1016/ j.gie.2007.09.038]
74. Oh HC, Seo DW, Kim SC, Yu E, Kim K, Moon SH, Park do H, Lee SS, Lee SK, Kim MH. Septated cystic tumors of the pancreas: is it possible to treat them by endoscopic ultrasonography-guided intervention? Scand J Gastroenterol 2009; 44: 242-247 [PMID: 18949629 DOI: 10.1080/00365520802495537]
75. DeWitt J, McGreevy K, Schmidt CM, Brugge WR. EUSguided ethanol versus saline solution lavage for pancreatic cysts: a randomized, double-blind study. Gastrointest Endosc 2009; 70: 710-723 [PMID: 19577745 DOI: 10.1016/ j.gie.2009.03.1173]
76. Levy MJ, Thompson GB, Topazian MD, Callstrom MR, Grant CS, Vella A. US-guided ethanol ablation of insulinomas: a new treatment option. Gastrointest Endosc 2012; 75: 200-206 [PMID: 22078104 DOI: 10.1016/j.gie.2011.09.019]
77. Chang KJ, Nguyen PT, Thompson JA, Kurosaki TT, Casey LR, Leung EC, Granger GA. Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in pa-tients with advanced pancreatic carcinoma. Cancer 2000; 88: 1325-1335 [PMID: 10717613]
78. Hecht JR, Bedford R, Abbruzzese JL, Lahoti S, Reid TR, Soetikno RM, Kirn DH, Freeman SM. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res 2003; 9: 555-561 [PMID: 12576418]
79. Hecht JR, Farrell JJ, Senzer N, Nemunaitis J, Rosemurgy A, Chung T, Hanna N, Chang KJ, Javle M, Posner M, Waxman I, Reid A, Erickson R, Canto M, Chak A, Blatner G, Kovacevic M, Thornton M. EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointest Endosc 2012; 75: 332-338 [PMID: 22248601 DOI: 10.1016/j.gie.2011.10.007]
80. Chang KJ, Lee JG, Holcombe RF, Kuo J, Muthusamy R, Wu ML. Endoscopic ultrasound delivery of an antitumor agent to treat a case of pancreatic cancer. Nat Clin Pract Gastroenterol Hepatol 2008; 5: 107-111 [PMID: 18253139 DOI: 10.1038/ ncpgasthep1033]
81. Chang KJ, Irisawa A. EUS 2008 Working Group document: evaluation of EUS-guided injection therapy for tumors. Gastrointest Endosc 2009; 69: S54-S58 [PMID: 19179171 DOI: 10.1016/j.gie.2008.10.057]
82. Herman JM, Wild AT, Wang H, Tran PT, Chang KJ, Taylor GE, Donehower RC, Pawlik TM, Ziegler MA, Cai H, Savage DT, Canto MI, Klapman J, Reid T, Shah RJ, Hoffe SE, Rosemurgy A, Wolfgang CL, Laheru DA. Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results. J Clin Oncol 2013; 31: 886-894 [PMID: 23341531 DOI: 10.1200/jco.2012.44.7516]
83. Sun S, Xu H, Xin J, Liu J, Guo Q, Li S. Endoscopic ultrasound-guided interstitial brachytherapy of unresectable pancreatic cancer: results of a pilot trial. Endoscopy 2006; 38: 399-403 [PMID: 16680642 DOI: 10.1055/s-2006-925253]
84. Jin Z, Du Y, Li Z, Jiang Y, Chen J, Liu Y. Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study. Endoscopy 2008; 40: 314-320 [PMID: 18283622 DOI: 10.1055/ s-2007-995476]